Bruce Stillman, Ph.D. is president and chief executive officer of Cold Spring Harbor Laboratory, discusses an area of immunology called adjuvant therapy, and how it is used to stimulate the body's immune system with agents that activate the immune system.

Bruce Stillman, Ph.D. is president and chief executive officer of Cold Spring Harbor Laboratory. He is interested in understanding the mechanism and control of DNA replication in higher cells. Working in baker's yeast, he has identified DNA sequences and proteins that interact to initiatiate chromosome duplication. “A very exciting area of immunology is what is called adjuvant therapy. And this is where you stimulate the body's immune system with agents that activate the immune system and make them hypersensitive to these foreign cells in our body such as cancer cells. And there are a number of clinical trials going on now where the immune system is being enhanced by these kinds of adjuvant or stimulant therapies, and there has been some success although I think there is still a lot of research in this area to do.”

cold spring harbor laboratory, bruce stillman, hallmarks, immune system, stimulant, immunology, adjuvant therapy